AU2017283482B2 - Amniotic fluid formulation for treatment of lung disorders - Google Patents

Amniotic fluid formulation for treatment of lung disorders Download PDF

Info

Publication number
AU2017283482B2
AU2017283482B2 AU2017283482A AU2017283482A AU2017283482B2 AU 2017283482 B2 AU2017283482 B2 AU 2017283482B2 AU 2017283482 A AU2017283482 A AU 2017283482A AU 2017283482 A AU2017283482 A AU 2017283482A AU 2017283482 B2 AU2017283482 B2 AU 2017283482B2
Authority
AU
Australia
Prior art keywords
haf
lung
formulations
agents
amniotic fluid
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
AU2017283482A
Other languages
English (en)
Other versions
AU2017283482A1 (en
Inventor
Carl Randall Harrell
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
MAM Holdings of West Florida LLC
Original Assignee
MAM Holdings of West Florida LLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by MAM Holdings of West Florida LLC filed Critical MAM Holdings of West Florida LLC
Publication of AU2017283482A1 publication Critical patent/AU2017283482A1/en
Application granted granted Critical
Publication of AU2017283482B2 publication Critical patent/AU2017283482B2/en
Ceased legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/48—Reproductive organs
    • A61K35/50—Placenta; Placental stem cells; Amniotic fluid; Amnion; Amniotic stem cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61H—PHYSICAL THERAPY APPARATUS, e.g. DEVICES FOR LOCATING OR STIMULATING REFLEX POINTS IN THE BODY; ARTIFICIAL RESPIRATION; MASSAGE; BATHING DEVICES FOR SPECIAL THERAPEUTIC OR HYGIENIC PURPOSES OR SPECIFIC PARTS OF THE BODY
    • A61H23/00—Percussion or vibration massage, e.g. using supersonic vibration; Suction-vibration massage; Massage with moving diaphragms
    • A61H23/02—Percussion or vibration massage, e.g. using supersonic vibration; Suction-vibration massage; Massage with moving diaphragms with electric or magnetic drive
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/0078—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy for inhalation via a nebulizer such as a jet nebulizer, ultrasonic nebulizer, e.g. in the form of aqueous drug solutions or dispersions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/06—Antianaemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61H—PHYSICAL THERAPY APPARATUS, e.g. DEVICES FOR LOCATING OR STIMULATING REFLEX POINTS IN THE BODY; ARTIFICIAL RESPIRATION; MASSAGE; BATHING DEVICES FOR SPECIAL THERAPEUTIC OR HYGIENIC PURPOSES OR SPECIFIC PARTS OF THE BODY
    • A61H33/00—Bathing devices for special therapeutic or hygienic purposes
    • A61H33/14—Devices for gas baths with ozone, hydrogen, or the like
    • A61H2033/143—Devices for gas baths with ozone, hydrogen, or the like with oxygen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61H—PHYSICAL THERAPY APPARATUS, e.g. DEVICES FOR LOCATING OR STIMULATING REFLEX POINTS IN THE BODY; ARTIFICIAL RESPIRATION; MASSAGE; BATHING DEVICES FOR SPECIAL THERAPEUTIC OR HYGIENIC PURPOSES OR SPECIFIC PARTS OF THE BODY
    • A61H2205/00—Devices for specific parts of the body
    • A61H2205/08—Trunk
    • A61H2205/084—Chest

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Pulmonology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Developmental Biology & Embryology (AREA)
  • Cell Biology (AREA)
  • Pain & Pain Management (AREA)
  • Dispersion Chemistry (AREA)
  • Zoology (AREA)
  • Otolaryngology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Rehabilitation Therapy (AREA)
  • Virology (AREA)
  • Immunology (AREA)
  • Pregnancy & Childbirth (AREA)
  • Reproductive Health (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Rheumatology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
AU2017283482A 2016-06-13 2017-06-13 Amniotic fluid formulation for treatment of lung disorders Ceased AU2017283482B2 (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US201662349352P 2016-06-13 2016-06-13
US62/349,352 2016-06-13
US15/290,271 US20170354692A1 (en) 2016-06-13 2016-10-11 Amniotic fluid formulation for treatment of lung disorders
US15/290,271 2016-10-11
PCT/US2017/037251 WO2017218535A1 (en) 2016-06-13 2017-06-13 Amniotic fluid formulation for treatment of lung disorders

Publications (2)

Publication Number Publication Date
AU2017283482A1 AU2017283482A1 (en) 2019-01-31
AU2017283482B2 true AU2017283482B2 (en) 2019-12-19

Family

ID=60572075

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2017283482A Ceased AU2017283482B2 (en) 2016-06-13 2017-06-13 Amniotic fluid formulation for treatment of lung disorders

Country Status (7)

Country Link
US (3) US20170354692A1 (enExample)
EP (1) EP3468571B1 (enExample)
JP (3) JP7126268B2 (enExample)
AU (1) AU2017283482B2 (enExample)
CA (1) CA3027489C (enExample)
ES (1) ES2912075T3 (enExample)
WO (1) WO2017218535A1 (enExample)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP5505760B2 (ja) 2005-09-27 2014-05-28 ティッシュテク・インコーポレーテッド 羊膜調製物及び精製組成物及びその使用方法
US9526770B2 (en) 2011-04-28 2016-12-27 Tissuetech, Inc. Methods of modulating bone remodeling
ES2846789T3 (es) 2012-07-11 2021-07-29 Tissuetech Inc Composiciones que contienen complejos HC-HA/PTX3 y métodos de uso de los mismos
WO2016111899A1 (en) * 2015-01-05 2016-07-14 Petrucci Gary M Methods and materials for treating lung disorders
US20160243288A1 (en) 2015-02-23 2016-08-25 Tissuetech, Inc. Apparatuses and methods for treating ophthalmic diseases and disorders
US10342831B2 (en) 2015-05-20 2019-07-09 Tissuetech, Inc. Composition and methods for preventing the proliferation and epithelial-mesenchymal transition of epithelial cells
WO2017062948A1 (en) * 2015-10-09 2017-04-13 Mam Holdings Of West Florida, Llc Amniotic fluid topical formulation for the treatment of eye disorders
TW201733600A (zh) 2016-01-29 2017-10-01 帝聖工業公司 胎兒扶持組織物及使用方法
US20180096104A1 (en) * 2016-10-05 2018-04-05 MED Inc. Disease management system
CN108434441A (zh) * 2018-04-17 2018-08-24 哈尔滨博翱生物医药技术开发有限公司 新型成纤维细胞生长因子-21类似物在治疗弥漫性间质性肺脏疾病中的应用
CN110812369A (zh) * 2018-08-10 2020-02-21 浙江楚沅生物科技有限公司 用于治疗组织坏死或改善心脏功能的药物
EP3858372A1 (en) * 2020-01-31 2021-08-04 AdVita Lifescience GmbH Human anti-inflammatory peptides for the inhalatory treatment of inflammatory pulmonary diseases
WO2021152119A1 (en) * 2020-01-31 2021-08-05 Advita Lifescience Gmbh Human anti-inflammatory peptides for the inhalatory treatment of inflammatory pulmonary diseases
CN113384300B (zh) * 2020-03-11 2022-05-20 肖娓珠 一种妇产科羊水取样保存装置
US20230135928A1 (en) * 2020-04-03 2023-05-04 University Of Utah Research Foundation Method for treating lung disease with cell-free amniotic fluid
US12377121B2 (en) 2020-04-10 2025-08-05 Zeo Scientifix, Inc. Compositions comprising nanoparticles, method of making and uses thereof
CA3204080A1 (en) * 2020-12-02 2022-06-09 Breathe Restore, Inc. Compositions, devices, and methods for treating respiratory disorders
EP4329834A4 (en) * 2021-04-27 2025-08-13 Avita Medical Americas Llc REGENERATIVE BIOACTIVE SUSPENSION DERIVED FROM FRESHLY DISAGGREGATED TISSUE AND METHODS OF USE IN CLINICAL THERAPIES
US12570949B2 (en) 2022-12-27 2026-03-10 AVITA Medical Americas, LLC Systems and devices for wound therapy and related methods of use
DE202023002794U1 (de) 2022-12-27 2024-07-15 AVITA Medical Americas, LLC Kassette zur Herstellung einer regenerativen epidermalen Suspension
US11944742B1 (en) * 2023-06-08 2024-04-02 Microneb Tech Holdings, Inc. Apparatus, methods, and systems for administering a medication to an animal
USD1112812S1 (en) 2023-12-22 2026-02-10 AVITA Medical Americas, LLC Tissue processing cartridge

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2015134946A1 (en) * 2014-03-06 2015-09-11 Amnio Technology Llc Amnion derived therapeutic compositions and methods of use
US9132156B1 (en) * 2014-06-15 2015-09-15 Amnio Technology Llc Acellular amnion derived therapeutic compositions

Family Cites Families (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US1699479A (en) 1928-04-27 1929-01-15 Lilly Co Eli Amniotic fluid and process of preparing it
US3752158A (en) 1970-11-23 1973-08-14 Snyder Manuf Co Inc Apparatus and method for suprapubic drainage of the urinary bladder
US4308875A (en) 1981-03-11 1982-01-05 Universal Medical Instrument Corporation Amniocentesis needle
US5436135A (en) 1985-09-02 1995-07-25 Pasteur Merieux Serums Et Vaccins New preparation of placenta collagen, their extraction method and their applications
US5219576A (en) 1988-06-30 1993-06-15 Collagen Corporation Collagen wound healing matrices and process for their production
US4977897A (en) 1988-08-17 1990-12-18 Robert Hurwitz Amniocentesis needle with improved sonographic visibility
US5000192A (en) 1990-01-02 1991-03-19 Sealfon Andrew I Prenatal specimen collection method
ATE276757T1 (de) 1995-06-07 2004-10-15 Organogenesis Inc Zusammensetzungen aus rekonstituierten kollagenfasersegmenten und verfahren zu ihrer herstellung
JP2731833B2 (ja) 1995-06-26 1998-03-25 大同ほくさん株式会社 海洋生物を原料とした代用皮膚
US7044945B2 (en) 2001-03-30 2006-05-16 Sand Bruce J Prevention of regression in thermal ciliary muscle tendinoplasty
WO2004026244A2 (en) 2002-09-18 2004-04-01 Emiliano Ghinelli Use of a human amniotic membrane composition for prophylaxis and treatment of diseases and conditions of the eye and skin
US20050079147A1 (en) 2003-10-14 2005-04-14 Bernard Delaey Wound healing compositions and uses
WO2006091546A2 (en) 2005-02-22 2006-08-31 The Johns Hopkins School Of Medicine Use of amniotic fluid (af) in treating ocular disease and injury
EP1712220A1 (en) * 2005-04-15 2006-10-18 PARI GmbH Spezialisten für effektive Inhalation Pharmaceutical aerosol composition
WO2007009062A2 (en) 2005-07-13 2007-01-18 Anthrogenesis Corporation Treatment of leg ulcers using placenta derived collagen biofabric
US20080064098A1 (en) 2006-06-05 2008-03-13 Cryo-Cell International, Inc. Procurement, isolation and cryopreservation of maternal placental cells
US8071135B2 (en) 2006-10-04 2011-12-06 Anthrogenesis Corporation Placental tissue compositions
AU2007318210B2 (en) 2006-10-06 2014-02-20 Celularity Inc. Native (telopeptide) placental collagen compositions
US20090054350A1 (en) 2007-08-23 2009-02-26 Jean-Louis Tayot Process for the sterile concentration of collagen preparations, and collagen preparations obtained
EP2197270B8 (en) 2007-09-07 2020-03-04 Surgical Biologics, LLC Placental tissue grafts and improved methods of preparing and using the same
US9095569B2 (en) 2008-04-18 2015-08-04 Collplant Ltd. Methods of generating and using procollagen
US9162006B2 (en) 2009-06-16 2015-10-20 Baxter International Inc. Hemostatic sponge
US20120010727A1 (en) 2010-07-06 2012-01-12 AFcell Medical Amnion and chorion constructs and uses thereof in sport injury surgeries
WO2014072468A1 (en) * 2012-11-09 2014-05-15 Velin-Pharma A/S Compositions for pulmonary delivery
US10485521B2 (en) * 2013-05-10 2019-11-26 MAM Holdings of West Florida, L.L.C. Method for obtaining sterile human amniotic fluid and uses thereof
US20140336600A1 (en) 2013-05-10 2014-11-13 Carl Randall Harrell Method for Obtaining Sterile Human Amniotic Fluid and Uses Thereof
WO2015134936A1 (en) 2014-03-06 2015-09-11 Amnio Technology Llc Amnion derived therapeutic compositions and methods of use
KR20160001267A (ko) 2014-06-27 2016-01-06 삼성전자주식회사 커넥터 플러그 및 커넥터 소켓
US10517903B2 (en) 2015-09-14 2019-12-31 Amnio Technology Llc Amnion derived therapeutic composition and process of making same
US9579350B1 (en) 2016-02-25 2017-02-28 MAM Holdings of West Florida, L.L.C. Human amniotic fluid preparation having long-term stability
AU2017237093B2 (en) * 2016-03-23 2022-12-01 Mimedx Group, Inc. Compositions and methods of treatment with amniotic fluid

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2015134946A1 (en) * 2014-03-06 2015-09-11 Amnio Technology Llc Amnion derived therapeutic compositions and methods of use
US9132156B1 (en) * 2014-06-15 2015-09-15 Amnio Technology Llc Acellular amnion derived therapeutic compositions

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
BRUCE K. RUBIN ET AL, "Emerging aerosol drug delivery strategies: From bench to clinic", ADVANCED DRUG DELIVERY REVIEWS, AMSTERDAM, NL, (2014-06-30), vol. 75, doi:10.1016/j.addr.2014.06.008, ISSN 0169-409X, pages 141 - 148 *
HALLMAN M ET AL, PEDIATRICS, AMERICAN ACADEMY OF PEDIATRICS, (1983-04-01), vol. 71, no. 4, ISSN 0031-4005, pages 473 - 482 *

Also Published As

Publication number Publication date
JP2023121866A (ja) 2023-08-31
US20180140641A1 (en) 2018-05-24
JP7126268B2 (ja) 2022-08-26
JP2021181496A (ja) 2021-11-25
EP3468571B1 (en) 2022-01-26
JP2019517597A (ja) 2019-06-24
US20230021477A1 (en) 2023-01-26
US11491189B2 (en) 2022-11-08
EP3468571A1 (en) 2019-04-17
AU2017283482A1 (en) 2019-01-31
CA3027489C (en) 2023-04-04
JP7371948B2 (ja) 2023-10-31
US20170354692A1 (en) 2017-12-14
WO2017218535A1 (en) 2017-12-21
ES2912075T3 (es) 2022-05-24
CA3027489A1 (en) 2017-12-21

Similar Documents

Publication Publication Date Title
JP7371948B2 (ja) 肺障害の処置のための羊水液剤
CA3015670C (en) Decellularized human amniotic fluid preparation having long-term stability
JP5878477B2 (ja) 骨の治癒を加速するためのバナジウム化合物の使用
US12171788B2 (en) Methods and materials for treating lung disorders
CN1143672C (zh) 含尿苷三磷酸的药物组合物
US9907821B2 (en) Amniotic fluid formulation for treatment of joint pain or disorders
JP6397984B2 (ja) 乾燥粉末ペプチド医薬
HK40007162B (en) Amniotic fluid formulation for treatment of lung disorders
US20220339099A1 (en) Compositions of interleukin-1 receptor antagonist
US20220184141A1 (en) Amniotic fluid formulation for treatment of joint pain or disorders
WO2023125432A1 (en) Antiviral peptides and methods of use thereof
AU2011205741B2 (en) Use of vanadium compounds to accelerate bone healing
CN101780096A (zh) 注射用丙泊酚磷酸酯及其制备方法和用途
Dal Negro et al. Use of aerosols in bronchiectasis patients
HK1034464A (en) Novel pharmaceutical compositions of uridine triphosphate
HK1178799B (en) Use of vanadium compounds to accelerate bone healing

Legal Events

Date Code Title Description
FGA Letters patent sealed or granted (standard patent)
MK14 Patent ceased section 143(a) (annual fees not paid) or expired
NB Applications allowed - extensions of time section 223(2)

Free format text: THE TIME IN WHICH TO PAY A RENEWAL FEE HAS BEEN EXTENDED TO 13 JAN 2022

NB Applications allowed - extensions of time section 223(2)

Free format text: THE TIME IN WHICH TO PAY A RENEWAL FEE HAS BEEN EXTENDED TO 13 JAN 2022

MK14 Patent ceased section 143(a) (annual fees not paid) or expired